Gennex Laboratories Ltd
BSE:531739

Watchlist Manager
Gennex Laboratories Ltd Logo
Gennex Laboratories Ltd
BSE:531739
Watchlist
Price: 13.85 INR -2.4% Market Closed
Market Cap: 3.4B INR

Gennex Laboratories Ltd
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Gennex Laboratories Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Gennex Laboratories Ltd
BSE:531739
Free Cash Flow
-₹943.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Free Cash Flow
₹18.5B
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Free Cash Flow
₹27B
CAGR 3-Years
10%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Free Cash Flow
₹89B
CAGR 3-Years
53%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Lupin Ltd
NSE:LUPIN
Free Cash Flow
₹29.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Free Cash Flow
₹13.6B
CAGR 3-Years
-4%
CAGR 5-Years
0%
CAGR 10-Years
N/A
No Stocks Found

Gennex Laboratories Ltd
Glance View

Market Cap
3.2B INR
Industry
Pharmaceuticals

Gennex Laboratories Ltd. engages in the manufacture of bulk drugs and intermediates products. The company is headquartered in Hyderabad, Telangana. The firm is engaged in the business of manufacturing of bulk drugs, intermediaries and biotech products. The firm has a robust product portfolio spread over major product segments encompassing expectorants, muscle relaxants, analgesic and anti-fungal. The firm operates through Pharmaceutical Products (Bulk Drugs) segment. The firm's products include active pharmaceutical ingredients, such as Guaifenesin USP/BP/EP/IP, which is an expectorant, (mucolyte); Methocarbamol USP, which is a relaxant (skeletal muscle relaxant); Phenazopyridine Hcl USP, which is an urinary tract analgesic; Fluconazole EP/USP, which is an anti-fungal product; Mephenesin IP/BP, which is a muscle relaxant; Chlorphenesin IP/BP, which is anti-fungal, and Melitracen Hcl, which is an antidepressant. The firm has manufacturing facilities in India which caters to both domestic and international markets.

GENNEX Intrinsic Value
12.15 INR
Overvaluation 12%
Intrinsic Value
Price

See Also

What is Gennex Laboratories Ltd's Free Cash Flow?
Free Cash Flow
-943.4m INR

Based on the financial report for Sep 30, 2025, Gennex Laboratories Ltd's Free Cash Flow amounts to -943.4m INR.

What is Gennex Laboratories Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 1Y
-159%

Over the last year, the Free Cash Flow growth was -159%.

Back to Top